CULVER CITY, Calif.--(BUSINESS WIRE)--NantHealth, LLC, a transformational company converging the power of genomic science and healthcare IT through a highly scalable cloud-based platform, today announced that it will be exhibiting at booth #5554 during the 2016 Healthcare Information and Management Systems Society (HIMSS16) Conference in Las Vegas on February 29-March 4, 2016. Recognized as one of the premiere healthcare industry conferences, HIMSS16 brings together healthcare professionals across the globe.
At the event, NantHealth will showcase its rich solutions portfolio that support the company’s vision of delivering on whole health systems integration and revolutionizing the patient-clinician experience by bringing real-time molecular and evidence-based insights to the point of care. Today, NantHealth’s solutions are found in over 2,000 leading hospitals and health systems worldwide, used by more than 75 percent of oncology practices in the United States, and serve more than 40 health plan customers—impacting nearly 100 million covered lives. In addition, NantHealth will continue to share the vision behind Cancer MoonShot 2020, a recently launched nationwide initiative that aims to accelerate the potential of combination immunotherapy as the next-generation standard of care for cancer patients.
“The fight against cancer and other life-threatening diseases needs to be a collaborative effort,” said Dr. Patrick Soon-Shiong, founder and chief executive officer of NantHealth and leader of the Cancer MoonShot 2020 program. “By combining the power of genomics and proteomics with best-in-class healthcare IT software applications, we stand a better chance of diagnosing a patient’s disease and prescribing the right treatment, while ensuring that providers have all the tools they need to effectively manage their patient populations, coordinate care across the continuum, and meet value-based reimbursement needs with payers.”
Dr. Soon-Shiong continued, “Our team is excited to be at HIMSS16 to showcase how NantHealth is making this vision into reality. With GPS Cancer™, a comprehensive multiomic-based test in development at NantOmics, LLC, we will provide a sneak peek into the power of DNA and RNA sequencing—with quantitative proteomics—that can help inform personalized treatment options for cancer patients. In addition, we will showcase our comprehensive suite of software solutions—recently expanded through our acquisition of NaviNet, Inc. in January 2016—that can manage a patient’s journey throughout the care continuum, while helping providers and payers to deliver better care quality at lower costs. Combined, these capabilities deliver on our 10-year vision of integrating our complex healthcare ecosystem from the knowledge domain, to the care delivery domain, and now to the payer domain, as a real-time, secure adaptive learning system.”
NantHealth will provide more information Cancer MoonShot 2020 and exhibit the following solutions at booth #5554 and in the Interoperability Showcase at HIMSS16:
- Precision Cancer Care: The industry’s most comprehensive solution—combining genomic and proteomic sequencing and population health management applications—that deliver omically-driven, evidenced-based treatment support for cancer patients while helping oncologists drive better outcomes at lower costs for cancer populations.
- Provider and Patient Engagement: A rich suite of applications—provider and patient portals, care coordination, clinical decision support, and others—that help health systems deliver collaborative, data-driven care for chronic populations.
- Wellness and Care Management: A set of applications and remote monitoring devices (e.g., weight scales, blood pressure cuffs, etc.) that help payers and self-insured employers proactively educate, inspire, and encourage healthy behaviors within their member or employee populations.
- Payer-Provider Collaboration: A suite of administrative and financial applications—eligibility and benefits, claims management, referrals, authorizations, document exchange, and more—that help payers and providers communicate in real-time, close care gaps, and meet value-based reimbursement objectives.
- Health Monitoring: A solution that captures patient data from medical devices and seamlessly delivers that data into electronic health records (EHR) or other data repositories, allowing clinicians to spend less time entering data and more time caring for patients.
- Knowledge and Insights: Solution combining risk stratification, decision support, and value-based analytics applications to help transform the wealth of data across health systems into actionable insights so physicians, executive management, and operational leaders can drive continuous improvement in care quality, outcomes, and efficiency.
About NantHealth
NantHealth, a member of the NantWorks
ecosystem of companies, is a transformational company converging the
power of genomic science and healthcare IT through a highly scalable
cloud-based platform, to provide actionable health information at the
point of care, in the time of need, anywhere, anytime. NantHealth works
to transform clinical delivery with actionable clinical intelligence at
the moment of decision, enabling clinical discovery through real-time
machine learning systems. The company’s technology empowers physicians,
patients, payers and researchers to transcend genomics into the world of
proteomics and the traditional barriers of today’s healthcare system. By
converging molecular science, computer science and big data technology,
the Nant Service Oriented Operating System (NantOS) platform empowers
physicians, patients, and payers to coordinate best care, monitor
outcomes and control cost in real time. This is the first operating
system of its kind in healthcare that is based on supply chain
principles and grid service oriented architecture and integrates the
knowledge base with the delivery system and the payment system, enabling
21st century coordinated care at a lower cost. For more information
please visit www.nanthealth.com and
follow Dr. Soon-Shiong on Twitter @DrPatSoonShiong.
About Cancer MoonShot 2020
The Cancer MoonShot 2020 Program
is the nation's most comprehensive cancer collaborative initiative
seeking to accelerate the potential of combination immunotherapy as the
next generation standard of care in cancer patients. This initiative
aims to explore a new paradigm in cancer care by initiating randomized
Phase II trials in patients at all stages of disease in 20 tumor types
in 20,000 patients within the next 36 months. These findings will inform
Phase III trials and the aspirational moonshot to develop an effective
vaccine-based immunotherapy to combat cancer by 2020. For more
information, visit http://www.CancerMoonShot2020.org.
